Inovio Stock Valuation

INO
 Stock
  

USD 1.73  0.11  5.98%   

What is the current enterprise value of Inovio Pharmaceuticals? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Inovio Pharmaceuticals, is its stock price multiplied by the total number of shares outstanding, calculating Inovio Pharmaceuticals' enterprise value requires a different approach. It uses Inovio Pharmaceuticals' balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Tangible Asset Value is expected to rise to about 520.9 M this year, although the value of Free Cash Flow will most likely fall to (222.6 M).
Inovio Pharmaceuticals retains a regular Real Value of $4.72 per share. The prevalent price of the firm is $1.73. Based on Macroaxis valuation methodology, the firm appears to be undervalued. Our model calculates the value of Inovio Pharmaceuticals from evaluating the firm fundamentals such as Return On Equity of (0.92) %, shares outstanding of 249.49 M, and Return On Asset of (0.43) % as well as inspecting its technical indicators and Probability Of Bankruptcy. In general, we encourage picking up undervalued assets and discarding overvalued assets since, at some point, asset prices and their ongoing real values will come together.
  
Inovio Pharmaceuticals Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Inovio Pharmaceuticals's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

Inovio Most Recent Valuation Data

Beta
1.0072
Change Receivables
11 M
Fiscal Year End
December
Property Plant And Equipment Net
29 M
Enterprise Value
244.5 M
Current Deferred Revenue
21.6 K
Undervalued
Today 1.73
Please note that Inovio Pharmaceuticals' price fluctuation is unstable at this time. Calculation of the real value of Inovio Pharmaceuticals is based on 3 months time horizon. Increasing Inovio Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Inovio Pharmaceuticals is useful when determining the fair value of the Inovio stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Inovio Pharmaceuticals. Since Inovio Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Inovio Stock. However, Inovio Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
4.72
Real Value
9.82
Upside
Estimating the potential upside or downside of Inovio Pharmaceuticals helps investors to forecast how Inovio stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Inovio Pharmaceuticals more accurately as focusing exclusively on Inovio Pharmaceuticals' fundamentals will not take into account other important factors:
Earnings
Estimates (6)
LowProjected EPSHigh
-1.32-1.26-1.14
Details
Hype
Prediction
LowEstimated ValueHigh
0.091.876.97
Details
Naive
Forecast
LowNext ValueHigh
0.037261.866.97
Details
8 Analysts
Consensus
LowTarget PriceHigh
6.0013.6235.00
Details
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Inovio Pharmaceuticals' intrinsic value based on its ongoing forecasts of Inovio Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Inovio Pharmaceuticals' closest peers. When choosing an evaluation method for Inovio Pharmaceuticals, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Inovio Pharmaceuticals Investments

360.45 Million

Inovio Valuation Drivers Correlation

Many accounts on the financial statements of Inovio Pharmaceuticals are highly interrelated and sometimes correlated. Consequently, when conducting Inovio's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Inovio
Click cells to compare fundamentals

Inovio Valuation Trend

Knowing Inovio Pharmaceuticals' actual value is paramount for traders to make sound investment determinations. Inovio Pharmaceuticals' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Inovio Pharmaceuticals' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Inovio Pharmaceuticals' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Inovio Market Cap

Inovio Pharmaceuticals is currently regarded as number one stock in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 68.79 Billion. Inovio Pharmaceuticals maintains roughly 459.06 Million in market capitalization contributing less than 1% to equities under Health Care industry.
Capitalization  Revenue  Valuation  Total debt  Workforce

Inovio Pharmaceuticals Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Inovio Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Inovio Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Inovio Pharmaceuticals competition to find correlations between indicators driving Inovio Pharmaceuticals's intrinsic value. More Info.
Inovio Pharmaceuticals is currently regarded as number one stock in price to sales category among related companies. It is currently regarded as number one stock in net asset category among related companies making up about  11,858,615  of Net Asset per Price to Sales. Average Assets is expected to rise to about 614.6 M this year. Tangible Asset Value is expected to rise to about 520.9 M this year. Comparative valuation analysis is a catch-all model that can be used if you cannot value Inovio Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Inovio Pharmaceuticals' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Inovio Pharmaceuticals' earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Inovio Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Inovio Pharmaceuticals and how it compares across the competition.

About Inovio Pharmaceuticals Valuation

The stock valuation mechanism determines the current worth of Inovio Pharmaceuticals on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Inovio Pharmaceuticals. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Inovio Pharmaceuticals based exclusively on its fundamental and basic technical indicators. By analyzing Inovio Pharmaceuticals's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Inovio Pharmaceuticals's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Inovio Pharmaceuticals. We calculate exposure to Inovio Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Inovio Pharmaceuticals's related companies.
Fiscal Year End
December
Industry
Biotechnology
Concentration
Biotechnology
Full Time Employees
317
Service Category
Biotechnology
Employer Id Number
33-0969592
Last ReportedProjected for 2022
Gross Profit1.8 M1.8 M
Profit Margin(64.75) (69.86) 

Inovio Pharmaceuticals Current Valuation Indicators

Valuation refers to the process of determining the present value of Inovio Pharmaceuticals and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Inovio we look at many different elements of the entity such as Inovio's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Inovio Pharmaceuticals' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Inovio Pharmaceuticals' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Inovio Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Inovio Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Inovio Pharmaceuticals' worth.
Please see Risk vs Return Analysis. You can also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Complementary Tools for analysis

When running Inovio Pharmaceuticals price analysis, check to measure Inovio Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inovio Pharmaceuticals is operating at the current time. Most of Inovio Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Inovio Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Inovio Pharmaceuticals' price. Additionally, you may evaluate how the addition of Inovio Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
CEO Directory
Screen CEOs from public companies around the world
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Is Inovio Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inovio Pharmaceuticals. If investors know Inovio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inovio Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
459.1 M
Quarterly Revenue Growth YOY
30.382
Return On Assets
(0.43) 
Return On Equity
(0.92) 
The market value of Inovio Pharmaceuticals is measured differently than its book value, which is the value of Inovio that is recorded on the company's balance sheet. Investors also form their own opinion of Inovio Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Inovio Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inovio Pharmaceuticals' market value can be influenced by many factors that don't directly affect Inovio Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inovio Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Inovio Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inovio Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.